No abstract available
MeSH terms
-
Adolescent
-
Antibodies, Bispecific* / administration & dosage
-
Antibodies, Bispecific* / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols* / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
-
Child
-
Child, Preschool
-
Drug Resistance, Neoplasm
-
Female
-
Humans
-
Inotuzumab Ozogamicin*
-
Male
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma* / pathology
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma* / therapy
-
Recurrence
-
Rituximab* / administration & dosage
-
Rituximab* / therapeutic use
-
Treatment Outcome
Substances
-
blinatumomab
-
Inotuzumab Ozogamicin
-
Antibodies, Bispecific
-
Rituximab